Sergey Dankvert underlined the need to strengthen scientific work carried out by the staff of the center. “If we don’t act in the scientific field, the desired results won’t be reached. Innovative products of ARRIAH should significantly increase their presence in Russia,” said the head of the service.
According to Ilya Chvala, FGBI ARRIAH Deputy Director for Research, the center is actively involved with import substitution of veterinary vaccines for food producing animals and poultry.
“We are focusing on the development of vaccines capable of providing for the biological safety of the country,” said Ilya Chvala.
He specified, that currently 10 new vaccines are under development at FGBI ARRIAH. They will be certified in 2023.
One of the new drugs is the MastitVak-EVA vaccine against bovine mastitis. According to the ARRIAH Deputy Director, this vaccine is based on the strains isolated in Russian livestock farms, and represents a unique product for Russia.
Scientists are also working on immunobiologicals for poultry. These include the Newcastle disease live dried vaccine (for broilers) and the vaccine against H9 avian influenza and Newcastle disease.
Besides that, the FGBI ARRIAH is developing a new vaccine against porcine reproductive and respiratory syndrome (PRRS).
In addition, scientists are working on new vaccines for aquaculture, including a product against salmon diseases.
Ilya Chvala also talked about vaccines for small pets, which is a new direction of work. Currently, due to the refusal of foreign companies to supply particular types of medicines for pets, the Russian market needs to replace those with Russian products.
ARRIAH scientists are currently working on "Karnikan-5", a combined vaccine for dogs, aimed at protecting animals from canine distemper, parvovirus and coronavirus enteritis, adenovirus infections and rabies.
Another vaccine is being developed for cats under the name “Carnifel”. It will be effective against panleukopenia, calicivirus, and viral rhinotracheitis in cats.
The Deputy Director of ARRIAH outlined another focus area. “The development of vaccines against bacterial infections is one of the strategies for combating antimicrobial resistance, and the first stages involve the development of autovaccines”, said Ilya Chvala.
The work of ARRIAH on new test systems for veterinary laboratories was also discussed at the meeting. There are plans to develop ten new methods and test systems for the diagnosis of infectious animal diseases.
